SMALLPOX
Clinical trials for SMALLPOX explained in plain language.
Never miss a new study
Get alerted when new SMALLPOX trials appear
Sign up with your email to follow new studies for SMALLPOX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine against mpox enters key trial in africa
⭐️ VACCINE ⭐️ Recruiting nowThis study tests an experimental mRNA vaccine called BNT166a to see if it is safe and can protect against mpox (monkeypox). About 310 healthy adults in Africa will receive either the vaccine or a placebo. The trial is double-blind, meaning neither participants nor doctors know wh…
Matched conditions: SMALLPOX
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Experimental drug targets smallpox and monkeypox after exposure
Disease control AVAILABLEThis trial tests the drug tecovirimat in people who have been exposed to or infected with orthopox viruses, including smallpox, monkeypox, and cowpox. Participants receive oral tecovirimat to see if it can control the infection and prevent serious complications. The study include…
Matched conditions: SMALLPOX
Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New poxvirus drug candidate tested in healthy people
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body processes a new drug called BSY001 in 76 healthy adults aged 18 to 50. Participants receive either the drug or a placebo, and researchers monitor side effects and drug levels in the blood. The goal is to gather safety infor…
Matched conditions: SMALLPOX
Phase: PHASE1 • Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC